SCHEMBL27905684

SCHEMBL27905684

Fc1ccccc1OCC1(COc2[c]cccc2)CC1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ KDM4E B2RXH2 4/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ CYP1A2 P05177 2/20 0.34
▸ CYP2D6 P10635 2/20 0.34
▸ CYP2C9 P11712 2/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ HPGD P15428 2/20 0.33
▸ FKBP1A P62942 1/20 0.32
▸ ADRB2 P07550 1/20 0.32
▸ RECQL P46063 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ DAO P14920 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27923629 0.83 CYP1A2 (0.35) L3MBTL1TDP1KMT2AMEN1CYP1A2
SCHEMBL27905683 0.82 SLC6A2 (0.36) L3MBTL1KMT2AMEN1ALDH1A1
SCHEMBL27923627 0.79 KCNA3 (0.34) TDP1ALDH1A1RECQL
SCHEMBL27905695 0.77 SLC6A2 (0.35) KMT2AMEN1CYP2C9ALDH1A1CYP3A4
SCHEMBL27905680 0.77 NPC1 (0.36) —
SCHEMBL27905697 0.74 PPARD (0.39) ALDH1A1
SCHEMBL27923626 0.71 LMNA (0.40) KDM4EKMT2AMEN1CYP2D6
SCHEMBL27905687 0.71 L3MBTL1 (0.41) L3MBTL1KDM4EKMT2AALDH1A1GAA
SCHEMBL6233331 0.71 SLC6A2 (0.39) L3MBTL1TDP1KDM4EKMT2AMEN1
SCHEMBL3326060 0.67 IDO1 (0.48) L3MBTL1TDP1KDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103097333-A Spirocyclically substituted 1,3-propane dioxide derivatives, methods for the production thereof and use of the same as medicament SANOFI SA 2013-05-08 — — CN disclosed
Send feedback